Insulet Q2 revenue up 32% to $396.5M; net income $27.3M vs prior year loss

INSULET CORP

2023-Q2 EPS reported $0.73 revenue$754,600,000

Total revenue $396.5M, +32.4% YoY; Omnipod revenue $380.5M (+33.2%).
U.S. Omnipod revenue $276.8M (+40.9%); International Omnipod $103.7M (+16.0%).
Net income $27.3M ($0.39 diluted EPS) vs net loss of $35.0M ($0.50 loss) in prior year.
Adjusted EBITDA $61.3M (15.5% of revenue) vs $27.6M (9.2%) prior year.
Launched Omnipod 5 in UK; submitted Omnipod 5 iOS App to FDA for clearance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.